SporeGen® has been made a partner on the Horizon 2020 EMI-TB Grant focusing on developing innovative mucosal vaccines to TB, utilising the SporeGen® “SporeVax” technology. The grant is led by
Read MoreSporeGen®is proud to be working with PATH and Dr. R. Aroian (University of Massachusetts) on a project that could ultimately lead to a significant impact on soil-transmitted helminth infections
Read MoreThe Horizon 2020 EMI-TB Grant, focusing on developing innovative mucosal vaccines for TB, of which SporeGen® is a contributing partner, has launched a new website. The website will develop over the
Read MoreThe SAPHIR project is an EU funded project whose full title is: Strengthening Animal Production and Health through the Immune Response. The general objective of SAPHIR is to generate
Read MoreThe Economist magazine has recently published a special study on the potential beneficial breakthroughs that may soon be made in the study of the Human Microbiome, it’s the reason SporeGen®
Read More